Financials
| Interim Results | Jun. 30, 2025 |
| Publication of 2024 Annual Report | Mar. 05, 2025 |
| Preliminary Results and Notice of AGM | Feb. 28, 2025 |
| Half-year Report | Jun. 18, 2024 |
| Annual Report & Accounts | Feb. 22, 2024 |
| Publication of FY22 Annual Report | Mar. 03, 2023 |
| Preliminary Results and Notice of AGM | Jan. 24, 2023 |
Proxies
| Result of AGM | Mar. 28, 2025 |
| Result of AGM | Mar. 27, 2024 |
| Result of AGM | Mar. 30, 2023 |
| Results of Annual General Meeting | Mar. 30, 2022 |
| Result of AGM | Mar. 24, 2021 |
| Results of Annual General Meeting | Mar. 20, 2020 |
| Publication of Annual Report and Notice of AGM | Jan. 23, 2020 |
Ownership Update
| Holding(s) in Company | Sep. 10, 2025 |
| Holding(s) in Company | Jul. 18, 2025 |
| Holding(s) in Company | Jul. 17, 2025 |
| Holding(s) in Company | Jul. 15, 2025 |
| Holding(s) in Company | Jul. 01, 2025 |
| Holding(s) in Company | Jun. 27, 2025 |
| Director/PDMR Shareholding | Apr. 10, 2025 |
Announcements
| Study confirms clinical utility of EpiSwitch CiRT | Sep. 04, 2025 |
| Collaboration with Google Cloud | Aug. 13, 2025 |
| Pfizer study on EpiSwitch biomarkers | Jul. 15, 2025 |
| OBD’s Oxford Lab accredited by UKAS | May. 09, 2025 |
| Board Changes | Mar. 17, 2025 |
| Expansion of OBD/Bupa UK insurance partnership | Mar. 13, 2025 |
| OBD partners with Regina Maria in Romania | Feb. 12, 2025 |